Phylogica Limited
PYC Therapeutics Limited, a development-stage biotechnology company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and VP-002, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on … Read more
Phylogica Limited (PH7) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2021: -0.049x
Based on the latest financial reports, Phylogica Limited (PH7) has a cash flow conversion efficiency ratio of -0.049x as of June 2021.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.66 Million) by net assets (€53.92 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Phylogica Limited - Cash Flow Conversion Efficiency Trend (2018–2021)
This chart illustrates how Phylogica Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Phylogica Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Phylogica Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BayCom Corp
NASDAQ:BCML
|
0.022x |
|
Argosy Research
TWO:3217
|
0.053x |
|
Guangzhou Frontop Digital Creative Technology Co. Ltd. A
SHE:301313
|
N/A |
|
Shandong Cynda Chemcial Co Ltd
SHG:603086
|
-0.021x |
|
Transcom Inc
TW:5222
|
0.029x |
|
Yongji Printing Co Ltd
SHG:603058
|
0.005x |
|
Cartesian Growth Corporation III Unit
NASDAQ:CGCTU
|
-0.001x |
|
DIAMOND HILL DL-01
F:BVE
|
N/A |
Annual Cash Flow Conversion Efficiency for Phylogica Limited (2018–2021)
The table below shows the annual cash flow conversion efficiency of Phylogica Limited from 2018 to 2021.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2021-06-30 | €53.92 Million | €-11.79 Million | -0.219x | -14.86% |
| 2020-06-30 | €30.20 Million | €-5.75 Million | -0.190x | +76.60% |
| 2019-06-30 | €6.30 Million | €-5.13 Million | -0.814x | +80.02% |
| 2018-06-30 | €1.65 Million | €-6.71 Million | -4.072x | -- |